Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion

Journal of Clinical Oncology

Volumn 23, Issue 22, 2005, Pages 5211-5216

  Gornik, Heather L ^a   Gerhard Herman, Marie ^a   Beckman, Joshua A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CYTOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; SURVIVAL TIME; MIDDLE AGED; NEOPLASM; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; RISK; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 24644499093     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.00.745     Document Type: Article

References (32)

1. Spodick DH: Acute cardiac tamponade. N Engl J Med 349:684-690, 2003
2. Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, et al: Clinical clues to the causes of large pericardial effusions. Am J Med 109:95-101, 2000
3. Levy PY, Corey R, Berger P, et al: Etiologic diagnosis of 204 pericardial effusions. Medicine 82:385-391, 2003
4. Corey GR, Campbell PT, Van Trigt P, et al: Etiology of large pericardial effusions. Am J Med 95:209-213, 1993
5. Colombo A, Olson HG, Egan J, et al: Etiology and prognostic implications of a large pericardial effusion in men. Clin Cardiol 11:389-394, 1988
6. Tsang TS, Enriquez-Sarano M, Freeman WK, et al: Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: Clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc 77:429-436, 2002
7. Lindenberger M, Kjellberg M, Karlsson E, et al: Pericardiocentesis guided by 2-D echocardiography: The method of choice for treatment of pericardial effusion. J Intern Med 253:411-417, 2003
8. Vaitkus PT, Herrmann HC, LeWinter MM: Treatment of malignant pericardial effusion. JAMA 272:59-64, 1994
9. Wang PC, Yang KY, Chao JY, et al: Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer. Chest 118:744-749, 2000
10. Tsang TS, Seward JB, Barnes ME, et al: Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc 75:248-253, 2000
11. Edoute Y, Kuten A, Ben-Haim SA, et al: Symptomatic pericardial effusion in breast cancer patients: The role of fluid cytology. J Surg Oncol 45:265-269, 1990
12. Edoute Y, Malberger E, Kuten A, et al: Symptomatic pericardial effusion in lung cancer patients: The role of fluid cytology. J Surg Oncol 45:121-123, 1990
13. Cullinane CA, Paz IB, Smith D, et al: Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy. Chest 125:1328-1334, 2004
14. Soler-Soler J, Sagrista-Sauleda J, Permanyer-Miralda G: Management of pericardial effusion. Heart 86:235-240, 2001
15. Meyers DG, Meyers RE, Prendergast TW: The usefulness of diagnostic tests on pericardial fluid. Chest 111:1213-1221, 1997
16. Seber A, Khan SP, Kersey JH: Unexplained effusions: Association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease. Bone Marrow Transplant 17:207-211, 1996
17. Schisterman EF, Whitcomb BW: Use of the Social Security Administration Death Master File for ascertainment of mortality status. Popul Health Metr 2:2, 2004
18. Sesso HD, Paffenbarger RS, Lee IM: Comparison of National Death Index and World Wide Web death searches. Am J Epidemiol 152:107-111, 2000
19. Kaplan E, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Treat Rep 50:163-170, 1966
21. Cox D: Regression models and life-tables. J R Stat Soc B 34:187-220, 1972
22. Wiener HG, Kristensen IB, Haubek A, et al: The diagnostic value of pericardial cytology: An analysis of 95 cases. Acta Cytol 35:149-153, 1991
23. Edoute Y, Malberger E, Kuten A, et al: Cytologic analysis of pericardial effusion complicating extracardiac malignancy. Am J Cardiol 69:568-571, 1992
24. Merce J, Sagrista-Sauleda J, Permanyer-Miralda G, et al: Should pericardial drainage be performed routinely in patients who have a large pericardial effusion without tamponade? Am J Med 105:106-109, 1998
25. Moores DW, Allen KB, Faber LP, et al: Subxiphoid pericardial drainage for pericardial tamponade. J Thorac Cardiovasc Surg 109:546-552, 1995
26. Wilkes JD, Fidias P, Vaickus L, et al: Malignancy-related pericardial effusion: 127 cases from the Roswell Park Cancer Institute. Cancer 76:1377-1387, 1995
27. Campbell PT, Van Trigt P, Wall TC, et al: Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy. Chest 101:938-943, 1992
28. Olsen PS, Sorensen C, Andersen HO: Surgical treatment of large pericardial effusions: Etiology and long-term survival. Eur J Cardiothorac Surg 5:430-432, 1991
29. Dosios T, Theakos N, Angouras D, et al: Risk factors affecting the survival of patients with pericardial effusion submitted to subxiphoid pericardiostomy. Chest 124:242-246, 2003
30. Van Trigt P, Douglas J, Smith PK, et al: A prospective trial of subxiphoid pericardiotomy in the diagnosis and treatment of large pericardial effusion: A follow-up report. Ann Surg 218:777-782, 1993
31. Daugherty CK: Examining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patients. Cancer Invest 22: 123-131, 2004
32. Lamont EB, Christakis NA: Complexities in prognostication in advanced cancer: "To help them live their lives the way they want to". JAMA 290:98-104, 2003